Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 23.13 1.89% 0.43
AXSM closed down 1.65 percent on Monday, May 20, 2019, on 73 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical AXSM trend table...

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 1.89%
NR7 Range Contraction 1.89%
Upper Bollinger Band Walk Strength 1.89%
Wide Bands Range Expansion 1.89%
Overbought Stochastic Strength 1.89%
Shooting Star Candlestick Bearish 0.22%
New 52 Week High Strength 0.22%
Upper Bollinger Band Walk Strength 0.22%
Wide Bands Range Expansion 0.22%
Overbought Stochastic Strength 0.22%

Older signals for AXSM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Medicine Pain Organ Systems Alzheimer's Disease Pain Management Osteoarthritis Chronic Pain Central Nervous System Disorders Perception Antidepressants Back Pain Chronic Condition Treatment Resistant Depression
Is AXSM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.22
52 Week Low 1.94
Average Volume 1,417,553
200-Day Moving Average 7.4917
50-Day Moving Average 15.8524
20-Day Moving Average 19.4965
10-Day Moving Average 21.563
Average True Range 1.3406
ADX 67.91
+DI 33.4548
-DI 6.0849
Chandelier Exit (Long, 3 ATRs ) 20.1982
Chandelier Exit (Short, 3 ATRs ) 18.3618
Upper Bollinger Band 24.2712
Lower Bollinger Band 14.7218
Percent B (%b) 0.84
BandWidth 48.980073
MACD Line 2.1907
MACD Signal Line 1.948
MACD Histogram 0.2427
Fundamentals Value
Market Cap 535.95 Million
Num Shares 23.6 Million
EPS -1.45
Price-to-Earnings (P/E) Ratio -15.66
Price-to-Sales 0.00
Price-to-Book 5.34
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.26
Resistance 3 (R3) 24.32 23.85 24.00
Resistance 2 (R2) 23.85 23.46 23.83 23.91
Resistance 1 (R1) 23.28 23.21 23.05 23.22 23.83
Pivot Point 22.81 22.81 22.70 22.79 22.81
Support 1 (S1) 22.24 22.42 22.01 22.18 21.57
Support 2 (S2) 21.77 22.17 21.75 21.49
Support 3 (S3) 21.20 21.77 21.40
Support 4 (S4) 21.14